escitalopram has been researched along with Social Anxiety Disorder in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alaie, I; Antoni, G; Faria, V; Fredrikson, M; Frick, A; Furmark, T; Gingnell, M; Hjorth, OR; Hoppe, JM; Hultberg, S; Jonasson, M; Lubberink, M; Månsson, KNT; Reis, M; Rosén, J; Wahlstedt, K | 1 |
| Alaie, I; Andersson, G; Antoni, G; Björkstrand, J; Carlbring, P; Engman, J; Faria, V; Fredrikson, M; Frick, A; Furmark, T; Gingnell, M; Hjorth, O; Jonasson, M; Lubberink, M; Reis, M; Wahlstedt, K | 1 |
2 trial(s) available for escitalopram and Social Anxiety Disorder
| Article | Year |
|---|---|
Expectancy effects on serotonin and dopamine transporters during SSRI treatment of social anxiety disorder: a randomized clinical trial.
Topics: Citalopram; Dopamine; Escitalopram; Female; Humans; Male; Phobia, Social; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins | 2021 |
Serotonin and dopamine transporter availability in social anxiety disorder after combined treatment with escitalopram and cognitive-behavioral therapy.
Topics: Brain; Cognitive Behavioral Therapy; Dopamine; Dopamine Plasma Membrane Transport Proteins; Escitalopram; Humans; Phobia, Social; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins | 2022 |